Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric Oxide and Lung Recruitment in Post-Cardiac Surgery
NCT06097026Recruiting
- Start
- Nov 2023
- Primary completion
- Aug 2024
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
Randomised, open-label trial of nitric oxide in pulmonary hypertension (PH) and Right ventricular dysfunction (RVD). Primary endpoint: Right ventricular-vascular coupling at 1 hour. Started Nov 2023; status: recruiting.
02
Drugs
nitric oxide
03
Conditions
pulmonary hypertension (PH)Right ventricular dysfunction (RVD)
Beyond the preview
Go deeper on NCT06097026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06097026.